New superior enzymes and customised purification resins for biopharma and regenerative medicines

Research & Development News Releases

Find the latest News in Research & Development

Page 47 of 109
New superior enzymes and customised purification resins for biopharma and regenerative medicines
New superior enzymes and customised purification resins for biopharma and regenerative medicines Learn More >
SIRION Biotech to collaborate with Sanofi on improved AAV capsids
SIRION Biotech to collaborate with Sanofi on improved AAV capsids Learn More >
UGA Biopharma to show high speed cell line development platform at BIO-Europe Spring® 2021
UGA Biopharma to show high speed cell line development platform at BIO-Europe Spring® 2021 Learn More >
Erdmann Design helps develop hemaPEN® coronavirus testing solution
Erdmann Design helps develop hemaPEN® coronavirus testing solution Learn More >
New study shows ecological benefits for enGenes Biotech -e<sup>x</sup>press technology
New study shows ecological benefits for enGenes Biotech -express technology Learn More >
Russian developer Mabscale in-licensed UGA Biopharma´s biosimilar cell lines
Russian developer Mabscale in-licensed UGA Biopharma´s biosimilar cell lines Learn More >
TAmiRNA shares microRNA biomarker insights at FIDELIO training webinar
TAmiRNA shares microRNA biomarker insights at FIDELIO training webinar Learn More >
Amplexor Be The Expert 2021 conference to focus on evolving regulation and new technologies
Amplexor Be The Expert 2021 conference to focus on evolving regulation and new technologies Learn More >
From Denmark to your lab – the journey of our Insulin Human AF
From Denmark to your lab – the journey of our Insulin Human AF Learn More >
Erdmann Design toothbrush solution shortlisted for further awards in 2021
Erdmann Design toothbrush solution shortlisted for further awards in 2021 Learn More >
Bachem showcasing well-stocked development pipeline at INTERPHEX Osaka
Bachem showcasing well-stocked development pipeline at INTERPHEX Osaka Learn More >
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) Learn More >
Page 47 of 109